ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.269,31
-0,67%
S&P 500
5.970,84
-1,11%
US Dollar vs BRL
6,19575
0,00%
Bitcoin
94.241,71
0,09%
Brent Oil
73,44
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Interleukin Genetics, (ILI)

  7. Interleukin Genetics, (ILI) Notícias

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:ILI
DataHoraFonteTítuloCódigoCompanhia
12/08/201017:07Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/08/201017:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
05/08/201009:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
05/08/201008:02Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
05/05/201007:02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
30/04/201020:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
30/04/201014:15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
13/04/201018:04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
25/03/201017:13Edgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
10/03/201019:11Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
09/03/201011:46Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
05/03/201016:52Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
04/02/201010:00PR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceAMEX:ILI
19/01/201010:30PR Newswire (US)LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in EuropeAMEX:ILI
06/01/201013:44Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)AMEX:ILIInterleukin Genetics,
06/01/201009:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:ILIInterleukin Genetics,
17/12/200910:30PR Newswire (US)Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone MiAMEX:ILI
07/12/200910:30PR Newswire (US)Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New YorkAMEX:ILI
02/12/200912:15PR Newswire (US)Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of OsteoarthritisAMEX:ILI
12/11/200919:20PR Newswire (US)Interleukin Genetics Reports Third Quarter 2009 Financial ResultsAMEX:ILI
05/11/200910:00PR Newswire (US)Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 ResultsAMEX:ILI
29/10/200909:00PR Newswire (US)Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic TestsAMEX:ILI
13/10/200908:00PR Newswire (US)Interleukin Genetics to Present Research Findings at Upcoming Medical MeetingsAMEX:ILI
23/09/200908:00PR Newswire (US)Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight LossAMEX:ILI
13/08/200917:20PR Newswire (US)Interleukin Genetics Reports Second Quarter 2009 Financial ResultsAMEX:ILI
06/08/200908:30PR Newswire (US)Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 ResultsAMEX:ILI
02/07/200908:00PR Newswire (US)Interleukin Genetics Announces Strategic Divestment of Alan James GroupAMEX:ILI
08/06/200910:00PR Newswire (US)Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to WellnessAMEX:ILI
05/06/200915:00PR Newswire (US)Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual MeetingAMEX:ILI
15/05/200910:00PR Newswire (US)Interleukin Genetics to Present at the 2009 BIO Business ForumAMEX:ILI
 Apresentando as notícias mais relevantes sobre:AMEX:ILI

Seu Histórico Recente

BOV
RCSL4
RECRUSUL PN
BOV
FICT3
Fictor Alimentos ON
BOV
PRIO3
PETRORIO ON
BOV
BRAV3
Brava Energia ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados